[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100233303":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":28,"responsibleParty":47,"collaborators":10,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":10,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"intestinal transplantation",null,"all performed intestinal transplants underwent the same Leuven intestinal transplant protocol",[13],"Procedure: intestinal transplantation",[15],{"type":16,"name":9,"description":10,"armGroupLabels":17,"otherNames":10},"PROCEDURE",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Jacques Pirenne, MD,PhD,MsC","CONTACT","+32 16 34 87 27","jacques.pirenne@uzleuven.be",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Laurens J Ceulemans, MD","+32 16 34 15 45","laurens.ceulemans@uzleuven.be",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"UZ Leuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":37,"coordinates":38},"Point",[39,40],4.70093,50.87959,{"lat":40,"lon":39},[43],{"name":44,"role":21,"phone":45,"phoneExt":10,"email":46},"Sarah Mertens","+32 16 34 29 61","sarah.mertens@uzleuven.be",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100233303",false,"NCT02314949","Leuven Tolerogenic Protocol for Intestinal Transplantation","A Multifactorial Immunomodulatory Protocol -Promoting T-regulatory Cells- Prolongs Graft and Patient Survival After Intestinal Transplantation","LP","Inclusion Criteria:\n\n* all patients awaiting intestinal transplantation\n\nExclusion Criteria:\n\n* living donation","ALL",{"count":58,"type":59},13,"ESTIMATED","OBSERVATIONAL","An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells.\n\nThis protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.",[63,64],"Organ Transplantation","Intestine",[66,67,68],"T-regulatory cells","Tolerogenic protocol","immunomodulation","2024-07-12",{"date":71,"type":72},"2024-07-15","ACTUAL",{"date":74,"type":10},"2000-10",{"date":76,"type":59},"2025-01",{"name":5,"class":6},1]